Entry Point Capital, LLC Collegium Pharmaceutical, Inc Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Entry Point Capital, LLC holds 2,675 shares of COLL stock, worth $92,715. This represents 0.13% of its overall portfolio holdings.
Number of Shares
2,675
Previous 2,240
19.42%
Holding current value
$92,715
Previous $87 Million
0.95%
% of portfolio
0.13%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding COLL
# of Institutions
239Shares Held
39.8MCall Options Held
84.2KPut Options Held
18.6K-
Black Rock Inc. New York, NY5.79MShares$201 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.41MShares$118 Million0.28% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.63MShares$91.3 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.37MShares$82.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.33MShares$80.9 Million2.23% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.18B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...